JUBLPHARMA

JUBILANT PHARMOVA

Mid Cap BSE: 530019 NSE: JUBLPHARMA
₹330.65
5.5 (1.69%)
  • Advice
  • Hold
As on 30 September, 2022 | 02:52

Jubilant Pharmova Share Price

Jubilant Pharmova Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in JUBILANT PHARMOVA

Start SIP

Jubilant Pharmova Share Returns

  • Over 1 Month -5.2%
  • Over 3 Month -4.44%
  • Over 6 Month -17.32%
  • Over 1 Year -47.77%

Jubilant Pharmova Key Statistics

P/E Ratio 17.5
PEG Ratio -0.3
Market Cap Cr 5,267
Price to Book Ratio 1
EPS 4.9
Dividend 1.5
Relative Strength Index 47.3
Money Flow Index 74.78
MACD Signal -3.62
Average True Range 13.11

Jubilant Pharmova Investment Rating

  • Master Rating:
  • Jubilant Pharmova has an operating revenue of Rs. 5,934.14 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 11% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 46%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is FAIR indicating the recent price performance, Buyer Demand at C which is evident from recent supply seen, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jubilant Pharmova Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 20029192020365
Operating Expenses Qtr Cr 20930242317311
Operating Profit Qtr Cr -4-2-5-3355
Depreciation Qtr Cr 9222211
Interest Qtr Cr 3888712
Tax Qtr Cr -1-1-16011
Net Profit Qtr Cr -5-3-588-135

Jubilant Pharmova Technicals

EMA & SMA

Current Price
330.65
5.5 (1.69%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 332.97
  • 50 Day
  • 342.62
  • 100 Day
  • 366.73
  • 200 Day
  • 423.67
  • 20 Day
  • 330.11
  • 50 Day
  • 343.11
  • 100 Day
  • 358.92
  • 200 Day
  • 423.26

Jubilant Pharmova Resistance and Support

PIVOT
₹326.69
Resistance
First Resistance 330.37
Second Resistance 335.59
Third Resistance 339.27
RSI 47.3
MFI 74.78
MACD Single Line -3.62
MACD -3.07
Support
First Resistance 321.47
Second Resistance 317.79
Third Resistance 312.57

Jubilant Pharmova Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 77,049 3,677,549 47.73
Week 109,002 4,123,531 37.83
1 Month 413,451 18,382,023 44.46
6 Month 187,664 7,722,373 41.15

Jubilant Pharmova Result Highlights

Jubilant Pharmova Synopsis

NSE-Medical-Diversified

Jubilant Pharmova is involved in the business activities of Manufacture of basic chemicals. Company’s Total Operating Revenue is Rs. 2709.50 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2021. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.
Market Cap 5,267
Sales 272
Shares in Float 7.80
No of funds 150
Yield 1.51
Book Value 4.11
U/D Vol ratio 1.7
LTDebt / Equity 39
Alpha -0.23
Beta 0.76

Jubilant Pharmova

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 50.68%50.68%50.68%
Mutual Funds 0.04%0.05%0.39%
Insurance Companies 0.04%
Foreign Portfolio Investors 23.47%23.45%23.18%
Financial Institutions/ Banks
Individual Investors 19.35%19.27%18.98%
Others 6.46%6.55%6.73%

Jubilant Pharmova Management

Name Designation
Mr. Shyam S Bhartia Chairman
Mr. Hari S Bhartia Co-Chairman & Manag. Director
Mr. Pramod Yadav Director
Mr. Arvind Chokhany Whole Time Director
Mr. Arun Seth Independent Director
Mr. Priyavrat Bhartia Director
Mr. Arjun Shanker Bhartia Director
Mr. Vivek Mehra Independent Director
Mr. Sushil Kumar Roongta Independent Director
Ms. Sudha Pillai Independent Director
Dr. Ashok Misra Independent Director
Mr. S Sridhar Independent Director

Jubilant Pharmova Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jubilant Pharmova Corporate Action

Date Purpose Remarks
2022-08-02 Quarterly Results
2022-05-27 Audited Results & Final Dividend
2022-02-04 Quarterly Results
2021-10-22 Quarterly Results
2021-07-23 Quarterly Results
Date Purpose Remarks
2022-08-12 FINAL Rs.5.00 per share(500%)Final Dividend
2021-08-06 FINAL Rs.5.00 per share(500%)Final Dividend

Jubilant Pharmova MF Shareholding

Name Amount(cr)
Nippon India Pharma Fund - Growth 4588
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 477
Motilal Oswal Nifty 500 Fund Regular Growth 348
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 344
ICICI Prudential S&P BSE 500 ETF 69

Jubilant Pharmova FAQs

What is Share Price of Jubilant Pharmova ?

Jubilant Pharmova share price is ₹330 As on 30 September, 2022 | 02:38

What is the Market Cap of Jubilant Pharmova ?

The Market Cap of Jubilant Pharmova is ₹5266.6 Cr As on 30 September, 2022 | 02:38

What is the P/E ratio of Jubilant Pharmova ?

The P/E ratio of Jubilant Pharmova is 17.5 As on 30 September, 2022 | 02:38

What is the PB ratio of Jubilant Pharmova ?

The PB ratio of Jubilant Pharmova is 1 As on 30 September, 2022 | 02:38

Q1FY23